David L. Melia

blueRover Inc.

Partnering against the pandemic: How temperature solutions ensure COVID-19 vaccine supply chain integrity

The COVID-19 pandemic has brought heightened public scrutiny of cold supply chains in the food and pharmaceutical industries worldwide. In this video, David L. Melia, Chief Strategic Officer at blueRover, discusses how a partnership with PHCbi has provided an end-to-end solution that enables digital temperature verification from manufacturer to consumer. Melia also explains how this temperature monitoring solution aims to ensure public safety during the COVID-19 vaccine rollout.



LIKE 4


David L. Melia
Health Sciences

David L. Melia

Biography

Chief Strategic Officer, blueRover Inc. More
Follow David

David L. Melia

blueRover Inc.

David L. Melia is a Chief Strategic Officer at KAAJENGA Vaccine & Food Safety, a wholly owned subsidiary of blueRover Inc, where he oversees the development, communication, and execution of the corporation’s strategic initiatives. David founded KAAJENGA after a 25-year career in consulting, eLearning, technology, and banking. He became Chief Executive Officer of Spring Valley Architectural Innovations in 2011 and at various stages throughout his career, he has held a range of executive management positions in both private and public organizations. These include Interchange, The Executive Knowledge Exchange, Networks North Inc. and BDC. During the pandemic, David has spent the past year working at the forefront of the COVID-19 vaccine rollout, educating the public on vaccine and food safety.